News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • U.S. and Iranian delegations are meeting in heavily secured Islamabad's Serena Hotel for mediated talks toward de-escalation.
  • Gasoline and diesel prices hit highs not seen since early 2022, forcing households and fleets to cut miles and costs.
  • Americans are split over U.S. strikes on Iran, with many worried about prolonged deployment and higher fuel costs.
  • Trump said fleets of empty oil tankers are heading to the U.S. to load crude, spotlighting energy logistics.
  • BioNTech and DualityBio reported a nearly 48% response rate in Phase 2 data for trastuzumab pamirtecan in endometrial cancer.
  • Chinese companies are redirecting investment in Brazil from large energy projects to consumer-facing businesses and EV-related services.
  • Marvell secured a $2 billion strategic investment and is being pitched as a tactical long for AI data-center buildout.

Latest Articles

General American Investors VP Increases Stake in 5.95% Preferred Stock

General American Investors VP Increases Stake in 5.95% Preferred Stock

Eugene S. Stark, General American Investors Co Inc's VP Administration/CCO/PFO, bought a combined 838 shares of the company's 5.95% Preferred Stock across two transactions on March 27 and March 30, 2026. The purchases totaled $20,902. After the trades, Stark's direct and indirect holdings in the preferred and common shares are detailed below. GAM's…

CME Group Director William R. Shepard Buys $437,101 of Stock

CME Group Director William R. Shepard Buys $437,101 of Stock

CME Group Director William R. Shepard purchased $437,101 worth of company stock on March 26, 2026, acquiring shares both directly and through a trust. The transactions occurred near the market price as the derivatives operator reports record open interest in U.S. Treasury products and moves to expand crypto trading hours.

Xilio Therapeutics Director Adds 5,000 Shares in March Transaction

Xilio Therapeutics Director Adds 5,000 Shares in March Transaction

Xilio Therapeutics director Shannon James Samuel purchased 5,000 shares of common stock on March 26, 2026, for a total of $43,949 at a reported price of $8.79 per share. The SEC filing notes transaction prices ranged from $8.6758 to $9.2499. After the purchase, Samuel directly owns 10,000 shares. The transaction occurs while XLO trades at $8.23 and…

Curanex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND Submission

Curanex Provides Business Update in Connection with 2025 Annual Report as Phyto-N Advances Toward Planned IND Submission

Curanex Pharmaceuticals reports significant progress in manufacturing, toxicology, intellectual property, and regulatory preparations for its lead drug candidate Phyto-N, targeting ulcerative colitis. The company completed GMP pilot batch production and pivotal toxicology studies, aiming for an IND submission by late 2026 and plans to initiate Phas…

Mexico Stocks Close Higher as Industrials and Consumer Names Lead Gains

Mexico Stocks Close Higher as Industrials and Consumer Names Lead Gains

Mexico's main equity index, the S&P/BMV IPC, finished the trading day up 0.60%, paced by strength in the Industrials, Consumer Goods & Services and Consumer Staples sectors. Leading individual gains included Industrias Peñoles, Grupo Carso and Grupo Bimbo, while airport operators posted the largest declines. Commodity markets saw crude oil climb an…

Colombian equities slide as COLCAP closes down 0.80%

Colombian equities slide as COLCAP closes down 0.80%

Colombian shares ended lower as the COLCAP index fell 0.80%, dragged by losses across Financials, Investment and Public Services. A few large-cap names posted gains, but major banks and service companies recorded some of the heaviest drops. Commodities and currency moves accompanied the trading day.

PepGen Shares Plunge After Phase 2 5 mg/kg Cohort Shows Minimal Benefit

PepGen Shares Plunge After Phase 2 5 mg/kg Cohort Shows Minimal Benefit

Shares of PepGen Ltd (NASDAQ:PEPG) plunged 44% in after-hours trading after the company disclosed Phase 2 FREEDOM2-DM1 data for the 5 mg/kg multiple ascending dose cohort. The treatment arm showed a mean splicing correction of 7.3% versus 6.8% for placebo, with six patients in the active group and two in placebo. Excluding one patient who experienc…

Meta Trials Instagram Plus Subscription, Adds Exclusive Story Tools

Meta Trials Instagram Plus Subscription, Adds Exclusive Story Tools

Meta Platforms has begun testing a paid Instagram subscription called Instagram Plus in select markets, offering subscribers a set of exclusive Story-related features. The company confirmed the experimental roll-out to TechCrunch; an Instagram spokesperson discussed the initiative with Bloomberg. Meta shares rose 2% on Monday following the confirma…

Future Money Acquisition Corporation Announces Completion of $112,000,000 Initial Public Offering, Including Partial Exercise of Overallotment Option

Future Money Acquisition Corporation Announces Completion of $112,000,000 Initial Public Offering, Including Partial Exercise of Overallotment Option

Future Money Acquisition Corporation, a Cayman Islands-based blank check company, successfully completed its IPO by offering 11.2 million units at $10 each, including a partial exercise of the underwriters' overallotment option. The company raised gross proceeds of $112 million and concurrently closed a private placement for an additional $3 millio…

Trading Day: Growth Fears Intensify as Markets Reprice Risk

Trading Day: Growth Fears Intensify as Markets Reprice Risk

Stocks and indices tumbled to multi-month lows while bond yields fell on mounting growth concerns tied to the Iran conflict. Oil pushed further above $100 a barrel, tech shares bore the brunt of the sell-off and market-based borrowing costs have surged at a moment when large technology companies are increasingly relying on debt to finance AI invest…

Badger Meter: Oversold Entry into Durable Smart-Water Growth

Badger Meter: Oversold Entry into Durable Smart-Water Growth

Badger Meter has reset materially from 2025 highs and now offers a buyable mix of recurring software revenue growth, improving margins and a fortress balance sheet. Valuation has come in to a reasonable multiple for a mid-teens growth story; this note lays out an actionable long-term trade with entry, stop and target and the catalysts and risks tha…

Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights

Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights

Glucotrack, Inc. reported its 2025 financial results and significant corporate progress including the receipt of three new U.S. patents for its implantable continuous blood glucose monitoring (CBGM) technology, a $4 million private placement, and preparations to file for Investigational Device Exemption (IDE) with the FDA to launch U.S. clinical tr…